AKBA
AKBA
NASDAQ · Biotechnology

Akebia Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.41
-0.01 (-2.80%)
As of Nov 7, 2:08 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +8,954.6% upside
Low Target $22.27
Average Target $37.45
High Target $46.32
Current Price $0.41
Current
$0.41
Target
$37.45
$22.27 $37.45 avg $46.32
Scenario Analysis
Bear Case
$22.27
5,284.4%
Low target
Base Case
$37.45
+8,954.6%
Avg target
Bull Case
$46.32
+11,099.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.13
-80.6% from high
52-Week Low
$0.45
+-8.1% from low
50-Day SMA
$0.81
-48.9% vs SMA
200-Day SMA
$1.13
-63.4% vs SMA
RSI (14)
30.7
Neutral
Target vs 52W High
$37.45
+1,658.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%